We are live on ! Find out more
HA

Hamel Associates Portfolio holdings

AUM $363M
1-Year Est. Return 24.39%
This Fund
S&P 500
This Quarter Est. Return
-1.72%
1 Year Est. Return
+24.39%
3 Year Est. Return
+50.64%
5 Year Est. Return
+68.03%
10 Year Est. Return
+174.56%
AUM
$311M
AUM Growth
-$16.6M
Cap. Flow
-$8.49M
Cap. Flow %
-2.73%
Top 10 Hldgs %
39.03%
Holding
77
New
3
Increased
18
Reduced
33
Closed
3

Sector Composition

Rank Sector Weight
1 Consumer Staples 16.26%
2 Technology 11.77%
3 Healthcare 10.21%
4 Industrials 9.71%
5 Financials 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TR icon
76
Tootsie Roll Industries
TR
$2.93B
-9,018
Closed -$263K
IBDP
77
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
-273,500
Closed -$6.89M

Similar funds

Hamel Associates's Q4 2024 Portfolio in Review

As of Q4 2024, Hamel Associates held 77 positions worth $311M, down 5.1% from $327M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Hamel Associates's Q4 2024 filing shows 3 new, 18 increased, 33 reduced and 3 closed positions. Its largest new stake was Campbell Soup: 77,515 shares worth $3.25M. The largest sale was iShares iBonds Dec 2024 Term Corporate ETF, an estimated $6.89M.

By sector, the portfolio is most concentrated in Consumer Staples at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • Hamel Associates's largest Q4 2024 buy was Campbell Soup: 77,515 shares worth $3.25M.
  • Hamel Associates added most to iShares iBonds Dec 2030 Term Corporate ETF in Q4 2024, an estimated $1.95M increase.
  • Hamel Associates's biggest Q4 2024 reduction was Dollar General, cutting an estimated $2.93M.
  • Hamel Associates fully exited iShares iBonds Dec 2024 Term Corporate ETF in Q4 2024, selling an estimated $6.89M.
  • Hamel Associates's ten largest holdings make up 39% of its $311M portfolio in Q4 2024.
  • Hamel Associates opened 3 new positions and closed 3 in Q4 2024.
  • Hamel Associates's portfolio value fell 5.1% quarter-over-quarter to $311M.

Based on Hamel Associates's 13F filing for Q4 2024, filed 5 Feb 2025.